loading

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

pulisher
Jul 28, 2026

Harmony Biosciences: WAKIX Cash Flow Funds Its Own Disruption (NASDAQ:HRMY) - Seeking Alpha

Jul 28, 2026
pulisher
Jul 28, 2026

The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals - Yahoo Finance

Jul 28, 2026
pulisher
Jul 28, 2026

Harmony Biosciences Holdings Inc (HRMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

Harmony Biosciences Holdings Inc (HRMY) Income Statement - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Harmony Biosciences Holdings Inc (HRMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Harmony Biosciences Holdings Inc (HRMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Harmony Biosciences Holdings Inc (HRMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Harmony Biosciences Holdings Inc - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Zacks Value Investor Highlights: HRMY, NVDA and VLO - TradingView

Jul 27, 2026
pulisher
Jul 26, 2026

Did CFO Exit and Reaffirmed 2026 Guidance Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st

Jul 26, 2026
pulisher
Jul 26, 2026

HRMY|Harmony Biosciences Holdings Inc|Price:35.320|Chg%:-0.480 - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits

Jul 26, 2026
pulisher
Jul 25, 2026

Harmony Biosciences Announces Preliminary Q2 Revenue, CFO Transition — Says Executive’s Departure Not Due To Any Disagreement - Stocktwits

Jul 25, 2026
pulisher
Jul 24, 2026

How Many Stocks Should You Own? - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

Harmony Biosciences Holdings Inc (HRMY) Institutional Confidence - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

ETFs Investing in Harmony Biosciences Holdings, Inc. Stocks - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

Harmony Biosciences (HRMY) Says Goodbye To Its CFO And Names An Interim Finance Chief - Yahoo Finance

Jul 23, 2026
pulisher
Jul 22, 2026

Harmony Biosciences interim principal financial officer Stephen Mollichella files initial beneficial ownership statement - Bitget

Jul 22, 2026
pulisher
Jul 22, 2026

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo! Finance Canada

Jul 22, 2026
pulisher
Jul 22, 2026

Harmony Biosciences (HRMY) officer details stock and option holdings - Stock Titan

Jul 22, 2026
pulisher
Jul 22, 2026

Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo! Finance Canada

Jul 22, 2026
pulisher
Jul 21, 2026

Harmony Biosciences Holdings Jumps 9.6% Amid Sector-Wide Rally - AlphaStreet

Jul 21, 2026
pulisher
Jul 21, 2026

Harmony Biosciences to report Q2 2026 results on August 4 - scanx.trade

Jul 21, 2026
pulisher
Jul 21, 2026

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026 - The Manila Times

Jul 21, 2026
pulisher
Jul 21, 2026

Harmony Biosciences will host a live Q2 results webcast on Aug. 4 - Stock Titan

Jul 21, 2026
pulisher
Jul 20, 2026

H.C. Wainwright reiterates Harmony Biosciences stock rating on demand beat - Investing.com UK

Jul 20, 2026
pulisher
Jul 20, 2026

H.C. Wainwright reiterates Harmony Biosciences stock rating on demand beat By Investing.com - Investing.com Nigeria

Jul 20, 2026
pulisher
Jul 20, 2026

Harmony Bio drops after CFO exit - MSN

Jul 20, 2026
pulisher
Jul 20, 2026

H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider

Jul 20, 2026
pulisher
Jul 20, 2026

Harmony Biosciences announces preliminary Q2 revenue, CFO transition — says executive’s departure not due to any disagreement - MSN

Jul 20, 2026
pulisher
Jul 19, 2026

Understanding the Setup: (HRMY) and Scalable Risk - Stock Traders Daily

Jul 19, 2026
pulisher
Jul 17, 2026

HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition - Yahoo Finance

Jul 17, 2026
pulisher
Jul 17, 2026

H.C. Wainwright reiterates Harmony Biosciences stock rating on strong Q2 results - Investing.com Nigeria

Jul 17, 2026
pulisher
Jul 17, 2026

H.C. Wainwright reiterates Harmony Biosciences stock rating on strong Q2 results By Investing.com - Investing.com South Africa

Jul 17, 2026
pulisher
Jul 17, 2026

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail

Jul 17, 2026
pulisher
Jul 17, 2026

Harmony Biosciences Posts Record Q2 WAKIX Revenue - TipRanks

Jul 17, 2026
pulisher
Jul 17, 2026

HRMY Reiterated by HC Wainwright & Co. -- Price Target Maintained at $55 - GuruFocus

Jul 17, 2026
pulisher
Jul 17, 2026

Harmony Biosciences CFO Reicin steps down, names Mollichella interim finance chief - Bitget

Jul 17, 2026
pulisher
Jul 17, 2026

Harmony Biosciences reaffirms 2026 net revenue outlook of $1 billion-$1.04 billion - Bitget

Jul 17, 2026
pulisher
Jul 16, 2026

Harmony Biosciences CFO Glenn Reicin Resigns - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony Biosciences (HRMY) CFO Resigns Amid Record Wakix Sales - GuruFocus

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition - Investing News Network

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony (HRMY) Maintains 2026 Revenue Forecast - GuruFocus

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony Bio stock drops after CFO exit (HRMY:NASDAQ) - Seeking Alpha

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony Biosciences reports record Q2 WAKIX sales of $261M - scanx.trade

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony (HRMY) Announces CFO Departure and Interim Appointment - GuruFocus

Jul 16, 2026
pulisher
Jul 16, 2026

Harmony Biosciences Holdings, Inc. Announces Chief Financial Officer Changes - marketscreener.com

Jul 16, 2026
$90.58
price down icon 2.44%
$119.52
price down icon 2.82%
$33.91
price down icon 1.77%
$58.43
price down icon 1.00%
$205.52
price up icon 0.02%
ONC ONC
$316.01
price down icon 1.88%
Capitalizzazione:     |  Volume (24 ore):